Sunho Biologics Inc (2898)

Currency in HKD
6.110
+0.010(+0.16%)
Closed·
2898 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2898 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.1106.120
52 wk Range
3.0007.300
Key Statistics
Bid/Ask
6.03 / 6.50
Prev. Close
6.11
Open
6.11
Day's Range
6.11-6.12
52 wk Range
3-7.3
Volume
7.4K
Average Volume (3m)
11.83K
1-Year Change
-5.43%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2898 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Sunho Biologics Inc Company Profile

Sunho Biologics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems. It offers IAH0968, an antibody-dependent cell mediated cytotoxicity enhanced monoclonal antibody, which is in the Phase II clinical trials for biliary tract carcinoma and colorectal cancer (CRC). The company also provides IAP0971 and IAE0972 immunocytokines, which have completed Phase I clinical trials for advanced solid tumors, including non-small cell lung cancer and CRC. In addition, its preclinical stage products include IBB0979, an immunocytokine for solid tumors; IBC0966, a clinical stage anti-PD-L1 antibody-signal regulatory protein bifunctional fusion protein for tumor specific immune responses; IBD0333 for solid tumor; IAN0982 for advanced solid tumors; ISH0988, an internally developed bifunctional antibody fusion protein for the treatment of systemic lupus erythematosus; and ISH0613, an internally developed bifunctional anti-inflammatory bispecific antibody for the treatment of inflammatory bowel disease. The company was founded in 2018 and is headquartered in Huzhou, China. Sunho Biologics, Inc. is a subsidiary of Sunho Wisdom Investments Limited.

Compare 2898 to Peers and Sector

Metrics to compare
2898
Peers
Sector
Relationship
P/E Ratio
−10.5x−25.5x−0.5x
PEG Ratio
−0.19−0.280.00
Price/Book
1.6x4.6x2.6x
Price / LTM Sales
22,072.2x7.3x3.2x
Upside (Analyst Target)
-−8.4%40.5%
Fair Value Upside
Unlock3.0%4.4%Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.29 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

2898 Income Statement

FAQ

What Stock Exchange Does Sunho Biologics Trade On?

Sunho Biologics is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Sunho Biologics?

The stock symbol for Sunho Biologics is "2898."

What Is the Sunho Biologics Market Cap?

As of today, Sunho Biologics market cap is 920.57M.

What Is Sunho Biologics's Earnings Per Share (TTM)?

The Sunho Biologics EPS (TTM) is -0.62.

From a Technical Analysis Perspective, Is 2898 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sunho Biologics Stock Split?

Sunho Biologics has split 0 times.

How Many Employees Does Sunho Biologics Have?

Sunho Biologics has 130 employees.

What is the current trading status of Sunho Biologics (2898)?

As of 25 Jul 2025, Sunho Biologics (2898) is trading at a price of 6.11, with a previous close of 6.11. The stock has fluctuated within a day range of 6.11 to 6.12, while its 52-week range spans from 3.00 to 7.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.